Cronos Group Inc.
NASDAQ Global MarketRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Cronos Group Inc. is a global cannabinoid company focused on building disruptive intellectual property through advancing cannabis research, technology and product development. The company offers a portfolio of cannabis and cannabis-derived products including dried flower, pre-rolls, edibles, vapes, oils, vaporizers, concentrates and tinctures under brands such as Spinach, PEACE NATURALS, Lord Jones and Cove; it targets adult-use recreational markets in Canada and medical markets in Israel through regulated channels like provincial distributors and pharmacies. Founded in 2012 and headquartered in Toronto, Ontario, Canada, Cronos Group operates an asset-light model emphasizing brand development, innovation in rare cannabinoids via biosynthesis partnerships like Ginkgo Bioworks, and geographic diversification across North America, Israel and select international markets. Recent developments include obtaining majority board control of Cronos GrowCo in July 2024 to expand cultivation capacity by 70% with completion targeted for Q2 2025 and initial sales in the second half of the year; providing C$30 million in convertible debt financing to High Tide Inc. in July 2025 to support retail ecosystem growth; and reporting Q3 2025 net revenue of $19.5 million with ongoing focus on margin expansion and flower supply improvements into 2026.
Company News
Cronos Completes Acquisition of CanAdelaar, Europe's Largest Adult-Use Cannabis Company
Fan-Favorite and Limited-Edition Spinach® Green Apple-Flavored Products are Returning for the Fall Season
CRON Stock Rises 17% in Three Months: Time to Buy the Dip or Cash Out?
Cronos Group Inc. to Hold 2026 Third Quarter Earnings Conference Call on November 5, 2026
Financial Survey: Eton Pharmaceuticals (NASDAQ:ETON) vs. Cronos Group (NASDAQ:CRON)
Cronos Group Inc. $CRON Shares Newly Acquired by Bank of America Corp DE
Cronos Group Inc. (CRON:CA) Analyst/Investor Day Transcript
Cronos Group Investor Day Highlights Cannabis Growth, Cash Flow and Global Ambitions
Cronos Hosts 2026 Investor Day
Head to Head Contrast: Lyra Therapeutics (OTCMKTS:LYRA) versus Cronos Group (NASDAQ:CRON)
Cronos: Invest In Cannabis With 50% Net Cash And GAAP Profitability
Cronos to Host 2026 Investor Day at its Cronos GrowCo Facility in Kingsville, Ontario
Are Medical Stocks Lagging Cronos Group (CRON) This Year?
Cronos' brand Spinach® Expands its Best-Selling Lineups of Edibles and Vapes
4 Healthcare Stocks to Safeguard Your Portfolio as Fed Plans Rate Hike
Surging Earnings Estimates Signal Upside for Cronos (CRON) Stock
Marijuana reform is emerging as a midterm elections issue on both sides of the aisle
Cronos Group: This Cannabis Name Isn't Reliant On U.S. Legalization Efforts
Cronos: Strong Quarter, And The Outlook For The Future Is Positive Thanks To M&A
Cronos Group Inc. (CRON:CA) Q2 2026 Earnings Call Transcript